Healthcare - Biotechnology - NASDAQ - US
$ 2.02
-2.88 %
$ 230 M
Market Cap
-1.23
P/E
Price Target
Average
182.89%
Revenue Forecast
Estimate
--1.51%
EBIT
Estimate
25.16%
Net Income
Estimate
2.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Fate Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for FATE of $5.71 , with forecasts ranging from a low of $4 to a high of $9 .
FATE Lowest Price Target
Wall Street Target
4 USD
98.02%
FATE Average Price Target
Wall Street Target
5.71 USD
182.89%
FATE Highest Price Target
Wall Street Target
9 USD
345.54%
REVENUE FORECAST
Revenue Forecast Chart FATE
EBIT FORECAST
EBIT Forecast Chart FATE
NET INCOME FORECAST
Net Income Chart FATE